Tuzistra XR (chlorpheniramine / codeine) Drug Interactions
A total of 454 drugs are known to interact with Tuzistra XR (chlorpheniramine / codeine).
- 112 major drug interactions
- 339 moderate drug interactions
- 3 minor drug interactions
Check for interactions
Most frequently checked interactions
View interaction reports for Tuzistra XR (chlorpheniramine / codeine) and the medicines listed below.
- amoxicillin / clavulanate
- Atarax (hydroxyzine)
- azithromycin
- benzonatate
- cyclobenzaprine
- Darvon Compound-65 (aspirin / caffeine / propoxyphene)
- Diflucan (fluconazole)
- Dilacor XR (diltiazem)
- enalapril
- fluconazole
- hydroxyzine
- Januvia (sitagliptin)
- Lorabid Pulvules (loracarbef)
- montelukast
- Procardia (nifedipine)
- Quillivant XR (methylphenidate)
- Rebetron (interferon alfa-2b / ribavirin)
- Remicade (infliximab)
- Tofranil (imipramine)
- Vioxx (rofecoxib)
Tuzistra XR (chlorpheniramine / codeine) alcohol/food interactions
There is 1 alcohol/food interaction with Tuzistra XR (chlorpheniramine / codeine)
Tuzistra XR (chlorpheniramine / codeine) disease interactions
There are 20 disease interactions with Tuzistra XR (chlorpheniramine / codeine) which include:
- impaired GI motility
- infectious diarrhea
- liver disease
- prematurity
- renal dysfunction
- acute alcohol intoxication
- drug dependence
- hypotension
- intracranial pressure
- respiratory depression
- anticholinergic effects
- asthma/COPD
- cardiovascular
- renal/liver disease
- adrenal insufficiency
- biliary spasm
- hypothyroidism
- seizure disorders
- urinary retention
- arrhythmias
More about Tuzistra XR (chlorpheniramine / codeine)
- Side Effects
- During Pregnancy
- Dosage Information
- Pricing & Coupons
- En Español
- Drug class: upper respiratory combinations
- FDA Alerts (6)
- FDA Approval History
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
